Impact of the COVID-19 Pandemic on Incidence of Asthma Exacerbations and Hospitalizations in US Subspecialist-Treated Patients with Severe Asthma: Results from the CHRONICLE Study

References

• Chung KF, Wenzel SE, Brozek JL, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014;43(2):343–373. doi:10.1183/09031936.00202013
   PubMed Web of Science ®Google Scholar
• Global Initiative for Asthma. Global strategy for asthma management and prevention; 2017. Available from: https://ginasthma.org/wp-content/uploads/2019/04/GINA-Severe-asthma-Pocket-Guide-v2.0-wms-1.pdf. Accessed April 28, 2021.
   Google Scholar
• Denlinger LC, Heymann P, Lutter R, Gern JE. Exacerbation-prone asthma. J Allergy Clin Immunol Pract. 2020;8(2):474–482. doi:10.1016/j.jaip.2019.11.009
   PubMed Web of Science ®Google Scholar
• Trevor J, Lugogo N, Carr W, et al. Severe asthma exacerbations in the United States: incidence, characteristics, predictors, and effects of biologic treatments. Ann Allergy Asthma Immunol. 2021;127(5):579–587.e571. doi:10.1016/j.anai.2021.07.010
   PubMed Web of Science ®Google Scholar
• Abe K, Miyawaki A, Nakamura M, Ninomiya H, Kobayashi Y. Trends in hospitalizations for asthma during the COVID-19 outbreak in Japan. J Allergy Clin Immunol Pract. 2021;9(1):494–496.e491. doi:10.1016/j.jaip.2020.09.060
   PubMed Web of Science ®Google Scholar
• Patrucco F, Benfante A, Villa E, Principe S, Scichilone N, Solidoro P. Severe asthma and COVID-19: lessons from the first wave. J Asthma. 2022;59(2):239–242. doi:10.1080/02770903.2020.1861622
   PubMed Web of Science ®Google Scholar
• Skevaki C, Karsonova A, Karaulov A, Xie M, Renz H. Asthma-associated risk for COVID-19 development. J Allergy Clin Immunol. 2020;146(6):1295–1301. doi:10.1016/j.jaci.2020.09.017
   PubMed Web of Science ®Google Scholar
• Terry PD, Heidel RE, Dhand R. Asthma in adult patients with COVID-19. Prevalence and risk of severe disease. Am J Respir Crit Care Med. 2021;203(7):893–905. doi:10.1164/rccm.202008-3266OC
   PubMed Web of Science ®Google Scholar
• Eguiluz-Gracia I, van den Berge M, Boccabella C, et al. Real-life impact of COVID-19 pandemic lockdown on the management of pediatric and adult asthma: a survey by the EAACI Asthma Section. Allergy. 2021;76(9):2776–2784. doi:10.1111/all.14831
   PubMed Web of Science ®Google Scholar
• Moreland A, Herlihy C, Tynan MA, et al. Timing of state and territorial COVID-19 stay-at-home orders and changes in population movement—United States, March 1–May 31, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(35):1198. doi:10.15585/mmwr.mm6935a2
   PubMed Web of Science ®Google Scholar
• Gallo O, Bruno C, Orlando P, Locatello LG. The impact of lockdown on allergic rhinitis: what is good and what is bad? Laryngoscope Investig Otolaryngol. 2020;5(5):807–808. doi:10.1002/lio2.459
   PubMed Web of Science ®Google Scholar
• Partridge E, McCleery E, Cheema R, et al. Evaluation of seasonal respiratory virus activity before and after the statewide COVID-19 shelter-in-place order in northern California. JAMA Netw Open. 2021;4(1):e2035281. doi:10.1001/jamanetworkopen.2020.35281
   PubMed Web of Science ®Google Scholar
• Olsen SJ, Winn AK, Budd AP, et al. Changes in influenza and other respiratory virus activity during the COVID-19 pandemic — United States, 2020–2021. MMWR Morb Mortal Wkly Rep. 2021;70(29):1013–1019. doi:10.15585/mmwr.mm7029a1
   PubMed Web of Science ®Google Scholar
• Ambrose CS, Chipps BE, Moore WC, et al. The CHRONICLE study of US adults with subspecialist-treated severe asthma: objectives, design, and initial results. Pragmat Obs Res. 2020;11:77–90. doi:10.2147/POR.S251120
   PubMed Web of Science ®Google Scholar
• Denlinger LC, Phillips BR, Sorkness RL, et al. Responsiveness to parenteral corticosteroids and lung function trajectory in adults with moderate-to-severe asthma. Am J Respir Crit Care Med. 2021;203(7):841–852. doi:10.1164/rccm.202002-0454OC
   PubMed Web of Science ®Google Scholar
• de Boer G, Braunstahl G-J, Hendriks R, Tramper-Stranders G. Asthma exacerbation prevalence during the COVID-19 lockdown in a moderate-severe asthma cohort. BMJ Open Resp Res. 2021;8(1):e000758. doi:10.1136/bmjresp-2020-000758
   PubMed Web of Science ®Google Scholar
• Kenyon CC, Hill DA, Henrickson SE, Bryant-Stephens TC, Zorc JJ. Initial effects of the COVID-19 pandemic on pediatric asthma emergency department utilization. J Allergy Clin Immunol Pract. 2020;8(8):2774–2776.e2771. doi:10.1016/j.jaip.2020.05.045
   PubMed Web of Science ®Google Scholar
• Salciccioli JD, She L, Tulchinsky A, Rockhold F, Cardet JC, Israel E. Effect of COVID-19 on asthma exacerbation. J Allergy Clin Immunol Pract. 2021;9(7):2896–2899.e2891. doi:10.1016/j.jaip.2021.04.038
   PubMed Web of Science ®Google Scholar
• Shah SA, Quint JK, Nwaru BI, Sheikh A. Impact of COVID-19 national lockdown on asthma exacerbations: interrupted time-series analysis of English primary care data. Thorax. 2021;76(9):860–866. doi:10.1136/thoraxjnl-2020-216512
   PubMed Web of Science ®Google Scholar
• Sheehan WJ, Patel SJ, Margolis RHF, et al. Pediatric asthma exacerbations during the COVID-19 pandemic: absence of the typical fall seasonal spike in Washington, DC. J Allergy Clin Immunol Pract. 2021;9(5):2073–2076. doi:10.1016/j.jaip.2021.02.008
   PubMed Web of Science ®Google Scholar
• Guijon OL, Morphew T, Ehwerhemuepha L, Galant SP. Evaluating the impact of coronavirus disease 2019 on asthma morbidity: a comprehensive analysis of potential influencing factors. Ann Allergy Asthma Immunol. 2021;127(1):91–99. doi:10.1016/j.anai.2021.03.018
   PubMed Web of Science ®Google Scholar
• Ho KS, Howell D, Rogers L, Narasimhan B, Verma H, Steiger D. The relationship between asthma, eosinophilia, and outcomes in coronavirus disease 2019 infection. Ann Allergy Asthma Immunol. 2021;127(1):42–48. doi:10.1016/j.anai.2021.02.021
   PubMed Web of Science ®Google Scholar
• Hurst JH, Zhao C, Fitzpatrick NS, Goldstein BA, Lang JE. Reduced pediatric urgent asthma utilization and exacerbations during the COVID-19 pandemic. Pediatr Pulmonol. 2021;56(10):3166–3173. doi:10.1002/ppul.25578
   PubMed Web of Science ®Google Scholar
• Ulrich L, Macias C, George A, Bai S, Allen E. Unexpected decline in pediatric asthma morbidity during the coronavirus pandemic. Pediatr Pulmonol. 2021;56(7):1951–1956. doi:10.1002/ppul.25406
   PubMed Web of Science ®Google Scholar
• Davies GA, Alsallakh MA, Sivakumaran S, et al. Impact of COVID-19 lockdown on emergency asthma admissions and deaths: national interrupted time series analyses for Scotland and Wales. Thorax. 2021;76(9):867–873. doi:10.1136/thoraxjnl-2020-216380
   PubMed Web of Science ®Google Scholar
• Cao L, Lee S, Krings JG, et al. Asthma in patients with suspected and diagnosed coronavirus disease 2019. Ann Allergy Asthma Immunol. 2021;126(5):535–541.e532. doi:10.1016/j.anai.2021.02.020
   PubMed Web of Science ®Google Scholar
• Robinson LB, Wang L, Fu X, et al. COVID-19 severity in asthma patients: a multi-center matched cohort study. J Asthma. 2021;59(3):1–14.
   Web of Science ®Google Scholar
• Bouazza B, Hadj-Said D, Pescatore KA, Chahed R. Are patients with asthma and chronic obstructive pulmonary disease preferred targets of COVID-19? Tuberc Respir Dis. 2021;84(1):22–34. doi:10.4046/trd.2020.0101
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. CDC updates, expands list of people at risk of severe COVID-19 illness [Press release]. Atlanta, GA, USA: Centers for Disease Control and Prevention; 2020 [June 25]. Available from: https://www.cdc.gov/media/releases/2020/p0625-update-expands-covid-19.html. Accessed August 9, 2022.
   Google Scholar
• Arora N, Lowe D, Sarsour N, et al. Asthma care during COVID-19: differences in attitudes and expectations between physicians and patients. J of Asthma. 2021;59(5):1–7.
   Web of Science ®Google Scholar
• Kaye L, Theye B, Smeenk I, Gondalia R, Barrett MA, Stempel DA. Changes in medication adherence among patients with asthma and COPD during the COVID-19 pandemic. J Allergy Clin Immunol Pract. 2020;8(7):2384–2385.
   PubMed Web of Science ®Google Scholar
• Dhruve H, d’Ancona G, Holmes S, Dhariwal J, Nanzer AM, Jackson DJ. Prescribing patterns and treatment adherence in patients with asthma during the COVID-19 pandemic. J Allergy Clin Immunol Pract. 2021;10(1):100–107.e2. doi:10.1016/j.jaip.2021.09.032
   PubMed Web of Science ®Google Scholar